Randomized Trials, Statistics, and Clinical Inference

Journal of the American College of Cardiology

Volumn 55, Issue 5, 2010, Pages 428-431

  Stone, Gregg W ^a   Pocock, Stuart J ^b  

^a NewYork Presbyterian Hospital   (United States)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

interpret; megatrials; results

Indexed keywords

FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HIRULOG; PACLITAXEL; RAPAMYCIN;

ACUTE HEART INFARCTION; BARE METAL STENT; CLINICAL STUDY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ELUTING STENT; EVIDENCE BASED MEDICINE; HUMAN; MAJOR CLINICAL STUDY; MEDICAL PRACTICE; MEDICAL RESEARCH; METHODOLOGY; MORTALITY; MULTICENTER STUDY; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY CONTROL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; REVIEW; STATISTICS;

CARDIOLOGY; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STATISTICS AS TOPIC;

EID: 74549137285     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2009.06.066     Document Type: Review

References (24)

1. Pocock S.J., and Elbourne D.R. Randomized trials or observational tribulations?. N Engl J Med 342 (2000) 1907-1909
2. Mauri L., Silbaugh T.S., Garg P., et al. Drug-eluting or bare-metal stents for acute myocardial infarction. N Engl J Med 359 (2008) 1330-1342
3. Stone G.W., Lansky A.J., Pocock S.J., et al. Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction. N Engl J Med 360 (2009) 1946-1959
4. Kaul S., and Diamond G.A. Trial and error: how to avoid commonly encountered limitations of published clinical trials. J Am Coll Cardiol 55 (2010) 415-427
5. DeMaria A.N. Publication bias and journals as policemen. J Am Coll Cardiol 44 (2004) 1707-1708
6. Altman D.G., and Bland J.M. Absence of evidence is not evidence of absence. BMJ 311 (1995) 485
7. Tepel M., Van der Giet M., Schwarzfeld C., et al. Prevention of radiographic contrast agent-induced reductions in renal function by acetylcysteine. N Engl J Med 343 (2000) 180-184
8. Vaitkus P.T., and Brar C. N-acetylcysteine in the prevention of contrast-induced nephropathy: publication bias perpetuated by meta-analyses. Am Heart J 153 (2007) 275-280
9. Guidance for the Use of Bayesian Statistics in Medical Device Clinical Trials. http://www.fda.gov/cdrh/osb/guidance/1601.pdf Accessed June 12, 2009
10. Granger C.B., Mahaffey K.W., Weaver W.D., et al. Pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute myocardial infarction. Circulation 108 (2003) 1184-1190
11. The APEX AMI Investigators. Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention. JAMA 297 (2007) 43-51
12. Tengs T.O., and Lin T.H. A meta-analysis of quality-of-life estimates for stroke. Pharmacoeconomics 21 (2003) 191-200
13. The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 329 (1993) 673-682
14. De Luca G., Suryapranata H., Stone G.W., et al. Coronary stenting versus balloon angioplasty for acute myocardial infarction. Int J Cardiol 119 (2007) 306-309
15. Kirtane A.J., Gupta A., Iyengar S., et al. Safety and efficacy of drug-eluting and bare metal stents: comprehensive meta-analysis of randomized trials and observational studies. Circulation 119 (2009) 3198-3206
16. Douglas P.S., Brennan J.M., Anstrom K.J., et al. Clinical effectiveness of coronary stents in elderly persons. J Am Coll Cardiol 53 (2009) 1629-1641
17. Stone G.W., Witzenbichler B., Guagliumi G., et al. Bivalirudin during primary PCI in acute myocardial infarction. N Engl J Med 358 (2008) 2218-2230
18. Doyle B.J., Rihal C.S., Gastineau D.A., and Holmes D.R. Bleeding, blood transfusion, and increased mortality after percutaneous coronary intervention. J Am Coll Cardiol 53 (2009) 2019-2027
19. Ware J.H., and Antman E.M. Equivalence trials. N Engl J Med 337 (1997) 1159-1161
20. LeLorier J., Grégoire G., Benhaddad A., et al. Discrepancies between meta-analyses and subsequent large randomized, controlled trials. N Engl J Med 337 (1997) 536-542
21. Thompson S.G., and Pocock S.J. Can meta-analyses be trusted?. Lancet 338 (1992) 1127-1130
22. Lumley T. Network meta-analysis for indirect treatment comparisons. Stat Med 21 (2002) 2313-2324
23. Higgins J.P.T., and Thompson S.G. Controlling the risk of spurious findings from meta-regression. Stat Med 23 (2004) 1663-1682
24. Pocock S.J., and Ware J.H. Translating statistical findings into plain English. Lancet 373 (2009) 1926-1928